IntelGenx Technologies Corp. IGXT Company Overview Stock

New Post Public Reply Private Reply Replies (0) Message Board

Sep 1, 2013 at 3:13 AM

IntelGenx Technologies Corp. IGXT Company Overview

Stock Message Board http://investorshangout.com/search?q=IGXT&...mp;yt1=Go!

IntelGenx Technologies Corp. IGXT Current Price and Quotes
0.546
Previous Close
0.521
Open
0.55

Daily Range
0.55 - 0.521
52wk Range
0.75 - 0.45

Volume
153,674
Dividend
N/A

Average Vol (3m)
234,157
Yield
N/A

IntelGenx Technologies Corp. IGXT

Company Verified Profile
Company Information
6425 Abrams
Ville St- Laurent, QC H4S 1X9
Canada

Website: http://www.intelgenx.com
Phone: 514-331-7440
Email: info@intelgenx.com

IntelGenx Technologies Corp. IGXT
IntelGenx, through its cutting edge formulation platforms, has developed a broad and diverse product portfolio, including products for the treatment of indications such as severe depression, hypertension, erectile dysfunction, migraine, insomnia, CNS indications, idiopathic pulmonary fibrosis, oncology and pain, as well as animal health products.
IntelGenx has three proprietary delivery platforms, including an immediate release oral film, VersaFilm, a mucoadhesive tablet, AdVersa and multi...

IntelGenx Technologies Corp. IGXT
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001098880
Fiscal Year End 12/31
OTC Marketplace OTCQX U.S.
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2003
Employees 11 a/o May 15, 2012
Company Officers/Contacts
Horst G. Zerbe, Ph.D CEO, President
Rajiv Khosla, Ph.D COO, CMO
Paul A. Simmons CFO
Ingrid Zerbe Corporate Secretary
Company Directors
Horst G. Zerbe, Ph.D Chairman
J. Bernard Boudreau
John Marinucci
Bernd J. Melchers
Rajiv Khosla, Ph.D
John (Ian) Troup
Service Providers
DAD/PAL
Dorsey & Whitney LLP
1400 Wewatta Street
Suite 400
Denver, CO, 80202
United States

Auditor/Accountant
RSM Richter Chamberland LLP
Legal Counsel
Dorsey & Whitney LLP
1400 Wewatta Street
Denver, CO, 80202
United States

Investor Relations Firm
Not Available

IntelGenx Technologies Corp. IGXT
IGXT Security Details
Share Structure
Market Value1 $28,779,890 a/o Aug 30, 2013
Shares Outstanding 52,710,421 a/o Aug 06, 2013
Float 33,904,559 a/o May 18, 2012
Authorized Shares 100,000,000 a/o May 18, 2012
Par Value 0.00001
Shareholders
Shareholders of Record 66 a/o Mar 29, 2012
Short Selling Data
Short Interest 295,208 (4.84%)
Aug 15, 2013
Significant Failures to Deliver No
Transfer Agent(s)
Philadelphia Stock Transfer, Inc.

IntelGenx Technologies Corp. IGXT Recent News

Aug 27, 2013 IntelGenx Corp. Receives Buprenorphine/Naloxone Sublingual Film Product Patent Infringement Complaint
Aug 23, 2013 OTC Daily Alert Stock Watch - IntelGenx (OTCQX: IGXT)
Aug 23, 2013 IntelGenx Receives Paragraph IV Certification Letter on Submission of ANDA for Forfivo XL(TM)
Aug 8, 2013 IntelGenx Reports Q2, 2013 Results and Corporate Development Highlights
Aug 7, 2013 IntelGenx Grants Stock Options
Jul 22, 2013 IntelGenx Announces Submission of ANDA for Buprenorphine/Naloxone Sublingual Film Product for the Treatment of Opiate Addiction
Jun 18, 2013 IntelGenx Announces FDA Acceptance of New Drug Application for Anti-Migraine VersaFilm(TM) Oral Film Product

IntelGenx Technologies Corp. IGXT Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 1,208 440 1,337 1,279
Cost of Revenue - - - -
Gross Profit 1,208 440 1,337 1,279
Operating Expenses
Research and Development 1,935 1,524 1,747 1,422
Sales, General and Admin. 1,433 1,325 2,548 1,196
Non-Recurring Items - - - -
Other 46 37 44 45
Operating Income (2,206) (2,446) (3,002) (1,384)
Income From Continuing Operations
Add'l Income/Expense Items (41) (3) 4 98
Earnings Before Interest and Tax (2,247) (2,449) (2,998) (1,286)
Interest Expense 3 3 98 784
Earnings Before Tax (2,250) (2,452) (3,096) (2,070)
Income Tax - - - (130)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,250) (2,452) (3,096) (1,940)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,250) (2,452) (3,096) (1,940)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (2,250) (2,452) (3,096) (1,940)

IGXT IntelGenx Technologies Corp. Research DD Guide

IGXT IntelGenx Technologies Corp. Stock Message Board http://investorshangout.com/search?q=IGXT&...mp;yt0=Go!
IGXT IntelGenx Technologies Corp. Stock Quote http://www.otcmarkets.com/stock/IGXT/quote
IGXT IntelGenx Technologies Corp. Stock Chart http://www.otcmarkets.com/stock/IGXT/chart
IGXT IntelGenx Technologies Corp. Company Info http://www.otcmarkets.com/stock/IGXT/company-info
IGXT IntelGenx Technologies Corp. Recent News http://www.otcmarkets.com/stock/IGXT/news
IGXT IntelGenx Technologies Corp. Financials http://www.otcmarkets.com/stock/IGXT/financials
IGXT IntelGenx Technologies Corp. Filings and Disclosure http://www.otcmarkets.com/stock/IGXT/filings
IGXT IntelGenx Technologies Corp. Short Sales http://www.otcmarkets.com/stock/IGXT/short-sales
IGXT IntelGenx Technologies Corp. Insider Disclosure http://www.otcmarkets.com/stock/IGXT/insider-transactions
IGXT IntelGenx Technologies Corp. Research Reports http://www.otcmarkets.com/stock/IGXT/research
IGXT IntelGenx Technologies Corp. Summary http://finance.yahoo.com/q?s=IGXT
IGXT IntelGenx Technologies Corp. Historical Prices http://finance.yahoo.com/q/hp?s=IGXT+Historical+Prices
IGXT IntelGenx Technologies Corp. Interactive Chart http://finance.yahoo.com/echarts?s=IGXT
IGXT IntelGenx Technologies Corp. Basic Chart http://finance.yahoo.com/q/bc?s=IGXT+Basic+Chart
IGXT IntelGenx Technologies Corp. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=IGXT+Basic+Tech.+Analysis
IGXT IntelGenx Technologies Corp. Headlines http://finance.yahoo.com/q/h?s=IGXT+Headlines
IGXT IntelGenx Technologies Corp. Press Releases http://finance.yahoo.com/q/p?s=IGXT+Press+Releases
IGXT IntelGenx Technologies Corp. Company Profile http://finance.yahoo.com/q/pr?s=IGXT+Profile
IGXT IntelGenx Technologies Corp. Key Statistics http://finance.yahoo.com/q/ks?s=IGXT+Key+Statistics
IGXT IntelGenx Technologies Corp. Industry http://finance.yahoo.com/q/in?s=IGXT+Industry
IGXT IntelGenx Technologies Corp. Major Holders http://finance.yahoo.com/q/mh?s=IGXT+Major+Holders
IGXT IntelGenx Technologies Corp. Insider Transactions http://finance.yahoo.com/q/it?s=IGXT+Insider+Transactions
IGXT IntelGenx Technologies Corp. Insider Roster http://finance.yahoo.com/q/ir?s=IGXT+Insider+Roster
IGXT IntelGenx Technologies Corp. Income Statement http://finance.yahoo.com/q/is?s=IGXT
IGXT IntelGenx Technologies Corp. Balance Sheet http://finance.yahoo.com/q/bs?s=IGXT
IGXT IntelGenx Technologies Corp. Cash Flow http://finance.yahoo.com/q/cf?s=IGXT+Cash+Flow&annual
IGXT IntelGenx Technologies Corp. Nasdaq http://www.nasdaq.com/symbol/IGXT
IGXT IntelGenx Technologies Corp. Market Watch http://www.marketwatch.com/investing/stock/IGXT
IGXT IntelGenx Technologies Corp. Bloomberg http://www.bloomberg.com/quote/IGXT:US
IGXT IntelGenx Technologies Corp. Morningstar http://quotes.morningstar.com/stock/s?t=IGXT
IGXT IntelGenx Technologies Corp. Bussinessweek http://investing.businessweek.com/research/st...icker=IGXT
IGXT IntelGenx Technologies Corp. Barchart http://www.barchart.com/quotes/stocks/IGXT
IGXT IntelGenx Technologies Corp. OTC Short Report http://otcshortreport.com/index.php?index=IGXT
IGXT IntelGenx Technologies Corp. Investopedia http://www.investopedia.com/markets/stocks/IGXT/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Southern Company Sparks Swift Power Restoration Post-Isaias

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

NARUTO Card Game Set for June 2027 Global Launch

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...